Warmblood Fragile Foal Syndrome

Watchlist
Retrieved
2021-01-18
Source
Trials
Genes
Drugs

Warmblood Fragile Foal Syndrome (WFFS) is a genetically induced disorder seen in horses. At first it was studied in Warmblood horses, but it is also present in Thoroughbreds, and potentially in any breed with Thoroughbred ancestry or outcrossing such as Quarter Horses, Standardbreds, and Morgans. It is autosomal recessive, so both sire and dam must be carriers for a foal to be affected. Foals with WFFS are naturally aborted, stillborn, or euthanized. WFFS is a genetic defect of connective tissue and foals born with it have hyper-extendible, abnormally thin, fragile skin that rips easily (similar to epidermolysis bullosa in humans).

It is associated with mutations in the gene coding for Lysyl hydroxylase 1 that result in a non functional enzyme.

A genetic test for Warmblood Fragile Foal Syndrome Type 1 was made commercially available in 2013. Approximately 9–11% of Warmblood horses are carriers, and a lower carrier frequency in Thoroughbreds and Knabstruppers.

Horses heterogynous for WFFS are phenotypically normal, so genetic testing is necessary to prevent breeding carriers.